Overall, GLP-1 RAs appear promising as adjunctive therapies for HS and psoriasis, especially in patients with coexisting metabolic disease
for dulaglutide (Trulicity), within 3 days
(PubMed) Johansson P, Dahlstrom O, Dahlstrom U, Alehagen U
Overall, the use of the GLP-1 receptor agonist-SGLT-2 inhibitor combination was associated with a 29% lower risk of major adverse cardiovascular events (7.6 v 10.7 per 1000 person years
The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom
Key takeaways Semaglutide is the active ingredient in Ozempic and Wegovy, and has been proven to help people lose weight in combination with lifestyle changes like diet and exercise